Overview
This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with Stage I pancreatic cancer stratified by pathologic risk factors.
Eligibility
Inclusion Criteria: Patients who underwent surgical resection and were pathologically
diagnosed as PDAC between 2010 and 2021.
-
Exclusion Criteria: Patients with pN1-N2, patients with pT3-T4, patients with distant
metastasis, patients who received neoadjuvant therapy, patients with R1 resection, and
patients who died due to perioperative mortality within 30 days.
-
